Trials / Active Not Recruiting
Active Not RecruitingNCT07289542
Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above
A Randomized, Blinded and Placebo-Control Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Above
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 420 (estimated)
- Sponsor
- Suzhou Abogen Biosciences Co., Ltd. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to evaluate the immunogenicity and safety of a single injection of two dose levels of ABO1105 in adults aged 50 years or above.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ABO1105 | Formulation for injection |
| DRUG | Placebo | 0.9% sodium chloride (normal saline) injection |
Timeline
- Start date
- 2025-09-15
- Primary completion
- 2026-01-07
- Completion
- 2027-10-15
- First posted
- 2025-12-17
- Last updated
- 2025-12-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07289542. Inclusion in this directory is not an endorsement.